Patient's Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL Study |
Kim, Yeon Jae
(Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital)
Lee, Byung Ki (Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital) Jung, Chi Young (Department of Internal Medicine, Keimyung University School of Medicine) Jeon, Young June (Department of Internal Medicine, Keimyung University School of Medicine) Hyun, Dae Sung (Department of Internal Medicine, Catholic University of Daegu School of Medicine) Kim, Kyung Chan (Department of Internal Medicine, Catholic University of Daegu School of Medicine) Yu, Sung Ken (Department of Internal Medicine, Yeungnam University College of Medicine) Choi, Hye Sook (Department of Internal Medicine, Dongguk University College of Medicine) Shin, Won Hyuk (Department of Internal Medicine, Sunlin Hospital, Handong Global University) Lee, Kwan Ho (Department of Internal Medicine, Yeungnam University College of Medicine) |
1 | Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19. DOI ScienceOn |
2 | Kim DS, Kim YS, Jung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-847. DOI ScienceOn |
3 | Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000;118:1278-1285. DOI ScienceOn |
4 | Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomia en la EPOC: pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449-1455. DOI ScienceOn |
5 | Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study. Arch Bronconeumol 2004;40:72-79. |
6 | Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. 2011 rev. Global Initiative for Chronic Obstructive Lung Disease, c2011 [cited 2012 Mar 25]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf. |
7 | Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757-765. DOI ScienceOn |
8 | Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004;98:932-937. DOI ScienceOn |
9 | Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005;118:1415. |
10 | Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J 2005;26:623-629. DOI ScienceOn |
11 | Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805. DOI ScienceOn |
12 | Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient's perception of exacerbations of COPD: the PERCEIVE study. Respir Med 2007;101:453-460. DOI ScienceOn |
13 | Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009;25:2043-2048. DOI ScienceOn |
14 | Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 2011;37:264-272. DOI ScienceOn |
15 | McCarley C, Hanneman SK, Padhye N, Smolensky MH. A pilot home study of temporal variations of symptoms in chronic obstructive lung disease. Biol Res Nurs 2007;9:8-20. DOI ScienceOn |
16 | Postma DS, Koeter GH, vd Mark TW, Reig RP, Sluiter HJ. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 1985;87:653-657. DOI ScienceOn |
17 | Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003;58:855-860. DOI ScienceOn |
18 | van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129:509-517. DOI ScienceOn |
19 | American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136. DOI ScienceOn |
20 | Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 1976;125:110-118. |
21 | Sensormedics. Pulmonary Utilities Operator's Manual: Predicted Normal Equations. Yorba Linda, CA: Sensormedics Co., 1988. |
22 | Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD: a review. Respir Med 2011;105:1422-1433. DOI ScienceOn |
23 | Monteleone P, Maj M. The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 2008;18:701-711. DOI ScienceOn |
24 | Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995;151:61-65. DOI ScienceOn |
25 | Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-1079. DOI ScienceOn |
26 | Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Ther Adv Respir Dis 2009;3:1-11. |
27 | Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:741-750. DOI ScienceOn |
28 | Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-940. DOI ScienceOn |
29 | Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency 7: Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994;49:162-170. DOI ScienceOn |
30 | Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007;101:146-153. DOI ScienceOn |
31 | Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-469. DOI ScienceOn |
32 | Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185. DOI ScienceOn |
33 | Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J 2009;34:648-654. DOI ScienceOn |
34 | Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010;80:112-119. DOI ScienceOn |
35 | van den Bemt L, Schermer T, Smeele I, et al. Monitoring of patients with COPD: a review of current guidelines' recommendations. Respir Med 2008;102:633-641. DOI ScienceOn |
36 | Benzo RP, Chang CC, Farrell MH, et al. Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration 2010;80:10-18. DOI ScienceOn |
37 | Partridge MR, Miravitlles M, Stahl E, Karlsson N, Svensson K, Welte T. Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD. Eur Respir J 2010;36:96-104. DOI ScienceOn |
![]() |